Algen Biotechnologies logo

Algen Biotechnologies

Emerging

AI drug discovery platform mapping functional gene networks for novel target identification; $12.63M from Viking Global and YC W20 applying computational genomics to decode disease biology.

20
AI Score
Grade D↑ Trending
AI Visibility Score (Beta)
HealthcareWebsiteUpdated March 2026

Company Overview

About Algen Biotechnologies

Algen Biotechnologies is a San Francisco-based drug discovery company that builds computational platforms to decode functional gene networks — using machine learning and genomic data to map the relationships between genes, understand how gene interactions drive disease, and identify novel therapeutic targets that traditional drug discovery approaches miss because they analyze genes in isolation. Founded in 2018 by Chun Hao Huang and Christine Du and a Y Combinator W20 graduate, Algen raised $12.63 million total including a $9 million Seed VC-II round led by Viking Global Investors in February 2022.

Business Model & Competitive Advantage

Algen's platform addresses a fundamental limitation in genomics-based drug discovery: most genetic analysis identifies individual disease-associated genes, but biology operates through networks — a gene's functional impact depends on which other genes it interacts with, which pathways are co-activated, and the cellular context. Algen's functional genomics platform maps these network relationships from large-scale genetic perturbation data, identifying which gene combinations drive disease phenotypes and which targets are central to therapeutic intervention.

Competitive Landscape 2025–2026

In 2025, Algen Biotechnologies competes in the AI drug discovery and computational genomics space with Recursion Pharmaceuticals (RXRX, AI-driven drug discovery), Schrödinger (computational chemistry and biology), Insitro, and academic-spinout gene network platforms for computational drug target identification. The AI drug discovery space has attracted significant investment — Recursion went public, Isomorphic Labs (DeepMind spinout) signed major pharma deals — validating the thesis that computational approaches can accelerate target identification and candidate selection. Viking Global's investment reflects institutional conviction in Algen's gene network approach. The 2025 strategy focuses on advancing lead therapeutic programs from the computational platform into experimental validation, building pharma partnerships for target licensing, and growing the platform's applicability across oncology, neurodegeneration, and metabolic disease.

Founded
2018
Curated content • Fact-checked and verified

Recent Activity

View all →

Key Differentiators

Emerging Innovator

Algen Biotechnologies is an emerging player bringing innovative solutions to the Healthcare market.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

20
↑ Trending

Based on estimated brand signals. Historical tracking coming soon.

Similar Brands

Browser Use logo

Browser Use

Developer Tools
B2bDeveloper ToolsPlatformSaasStartup

Browser Use is an open-source project that provides a Python library allowing AI agents and large language models to control web browsers as a tool. The library sits between LLM APIs and browser autom

Oracle Health logo

Oracle Health

Healthcare
HealthtechNorth AmericaB2b

Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve

athenahealth logo

athenahealth

Healthcare
B2bCloud NativeEnterpriseErpHealthtechNorth AmericaSaas

athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on

Veeva Systems logo

Veeva Systems

Healthcare Tech
B2bHealthtechSaasPublic

Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv

Idexx Laboratories logo

Idexx Laboratories

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu

Revvity logo

Revvity

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provid

For Algen Biotechnologies

Claim This Profile

Are you from Algen Biotechnologies? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Algen Biotechnologies Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Algen Biotechnologies vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →